- •Melanoma incidence rates in South-Eastern Europe were uniformly increasing over the 2000–2010 period.
- •Incidence rates were higher in men than in women at middle and older ages in most countries.
- •Trends in mortality rates diverged but were less favourable than in North-Western Europe.
- •Empowering cancer registration in the region will be essential for monitoring progress.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Cancer
- Cancer incidence in five continents, vol. X. 2013 (Lyon)
- Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.Eur J Cancer. 2005; 41: 28-44
- Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.Eur J Cancer. 2005; 41: 45-60
- Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.Eur J Cancer. 2005; 41: 2040-2059
- Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials.J Clin Oncol. 2013; 31: 2337-2346
- Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.Int J Cancer. 2015; 136: E359-E386
- GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11.2013 ([Internet])
- International trends in the incidence of malignant melanoma 1953–2008-are recent generations at higher or lower risk?.Int J Cancer. 2013; 132: 385-400
- Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.Int J Cancer. 2003; 107: 119-126
- Cancer incidence and mortality patterns in South Eastern Europe in the last decade: gaps persist compared with the rest of Europe.Eur J Cancer. 2013; 49: 1683-1691
European Parliament resolution of 10th April 2008 on combating cancer in the enlarged European Union (2009/C 247 E/04). Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.CE.2009.247.01.0011.01.ENG [accessed 23.06.14].
Treaty establishing the European Community (Amsterdam consolidated version) Part Three: Community policies. Title XIII: Public health. Article 152. Available from: http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:11997E152 [accessed 09.03.15].
European Commission website. Available from: http://ec.europa.eu/enlargement/countries/check-current-status/index_en.htm [accessed 14.04.14].
- Incidence and mortality trends of melanoma in Croatia.Croat Med J. 2012; 53: 135-140
- Melanoma incidence and mortality in Europe: new estimates, persistent disparities.Br J Dermatol. 2012; 167: 1124-1130
EUROCOURSE Project website. Available from: http://www.eurocourse.org/ [accessed 14.04.14].
- Uses of cancer registries for public health and clinical research in Europe: results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010–2012.Eur J Cancer. 2015; 51: 1039-1049
- Joinpoint Regression Program, Version 4.0.4. Statistical Methodology and Applications Branch, Surveillance Research Program. National Cancer Institute, May 2013
- Permutation tests for joinpoint regression with applications to cancer rates.Stat Med. 2000; 19 (correction 2001;20(4):655): 335-351
Hammarström H, Forkel R, Haspelmath M, Bank S. Glottolog 2.4. Leipzig: Max Planck Institute for Evolutionary Anthropology. Available from: http://glottolog.org [accessed 06.10.14].
- Data provided on request through personal communication.October 24, 2014 (Available from:)
- Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future.Br J Dermatol. 2012; 167: 99-104
- Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study.Eur J Cancer. 2015; 51: 2179-2190
World Bank 2010. Available from: http://data.worldbank.org/indicator/SH.XPD.PCAP/countries [accessed 6.10.14].
- Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.Eur J Cancer. 2004; 40: 1045-1052
- Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.J Eur Acad Dermatol Venereol. 2014; 28: 1170-1178
- Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980.Ann Oncol. 2013; 24: 2657-2671
- The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations.Eur J Cancer. 2015; 51: 869-878
- The validity and practicality of sun-reactive skin types I through VI.Arch Dermatol. 1988; 124: 869-871
EUROSUN project website. Available from: http://www.eurosun-project.org/ [accessed 23.06.14].
- The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010.J Eur Acad Dermatol Venereol. 2011; 25: 1455-1465
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study.Lancet Oncol. 2014; 15: 23-34
- Epidemiologija kožnega raka (Epidemiology of skin cancer, in Slovenian).in: Luzar B. Novosti v dermatopatologiji (Update on dermatopathology, in Slovenian). Proceedings of XL. memorialni sestanek profesorja Janeza Plečnika, Ljubljana 3–4 December 2009. Ljubljani Inštitut za Patol. Med. Fak., 2009 ([COBISS.SI-ID 26570201])
- Skin biopsy rates and incidence of melanoma: population based ecological study.BMJ. 2005; 331: 481
- Increasing time trends of thin melanomas in The Netherlands: what are the explanations of recent accelerations?.Eur J Cancer. 2015; 51: 2833-2841
- Cancer incidence in five continents, vol. IX. 2007 (Lyon)
- Power analysis to detect time trends on population-based cancer registries data: when size really matters.Eur J Cancer. 2015; 51: 1082-1090
- Melanoma: smart therapeutic strategies in immuno-oncology.Nat Rev Clin Oncol. 2014; 11: 181-182
- Cutaneous melanoma.Lancet. 2014; 383: 816-827
- Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma.J Clin Oncol. 2015; 33: 1889-1894
- Genetic alterations and personalized medicine in melanoma: progress and future prospects.J Natl Cancer Inst. 2014; 106 (djt435)
- Improved overall survival in melanoma with combined dabrafenib and trametinib.N Engl J Med. 2015; 372: 30-39
- The advantage of women in cancer survival: an analysis of EUROCARE-4 data.Eur J Cancer. 2009; 45: 1017-1027